Molecular Formula | C23H37N5O6 |
Molar Mass | 479.57 |
Density | 1.209±0.06 g/cm3(Predicted) |
Boling Point | 771.3±60.0 °C(Predicted) |
pKa | 11.25±0.46(Predicted) |
Storage Condition | 2-8°C |
Physical and Chemical Properties | Bioactive Boc-Val-Cit-PAB is a degradable (cleavable) ADC linker that can be used to synthesize antibody-coupled drugs (ADC). |
Use | The Boc-Val-Cit-PAB of use is a cleavable ADC linker for the synthesis of antibody-drug conjugates (ADCs). |
In vitro study | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. |
In vivo study | The ADC is composed of an antibody, and the ADC cytotoxin is bound to the antibody via the ADC linker. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.085 ml | 10.426 ml | 20.852 ml |
5 mM | 0.417 ml | 2.085 ml | 4.17 ml |
10 mM | 0.209 ml | 1.043 ml | 2.085 ml |
5 mM | 0.042 ml | 0.209 ml | 0.417 ml |
In vivo studies
ADC is composed of antibodies, which bind ADC cytotoxins to antibodies through ADC connectors.
Target
Cleavable
in vitro studies
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
use | Boc-Val-Cit-PAB are cleavable ADC connectors for the synthesis of antibody-drug conjugates (ADC). |
in vivo study | ADC consists of antibodies, which bind ADC cytotoxins to antibodies through ADC connectors. |
biological activity | Boc-Val-Cit-PAB is a degradable (cleavable) ADC linker that can be used to synthesize antibody-coupled drugs (ADC). |
target | Cleavable |
in vitro study | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.